163 related articles for article (PubMed ID: 25102762)
1. Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital.
Mosimann V; Cavassini M; Hugli O; Mamin R; Achtari C; Peters S; Darling KE
HIV Med; 2014 Nov; 15(10):631-4. PubMed ID: 25102762
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
4. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
5. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
6. Association between HIV/AIDS and malignancies in a Nigerian tertiary institution.
Ocheni S; Aken'Ova YA
West Afr J Med; 2004; 23(2):151-5. PubMed ID: 15287296
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
8. Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I.
Merz L; Zimmermann S; Peters S; Cavassini M; Darling KE
Oncologist; 2016 Oct; 21(10):1176-1182. PubMed ID: 27440062
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of human immunodeficiency virus type 1 infection in childhood malignancy in Zimbabwe.
Chitsike I; Siziya S
Cent Afr J Med; 1998 Oct; 44(10):242-5. PubMed ID: 10101432
[TBL] [Abstract][Full Text] [Related]
10. HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study.
D'Addario G; Dieterle A; Torhorst J; Maibach R; Stahel R; Egli F; Lohri A; Cavalli F; Fey M; Ketterer N; Cerny T
Leuk Lymphoma; 2003 Jan; 44(1):133-8. PubMed ID: 12691153
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of clinical diseases in HIV-infected adults at the Lagos University Teaching Hospital: a five-year experience [1992-1996].
Akinsete I; Akanmu AS; Okany CC
Afr J Med Med Sci; 1998; 27(3-4):147-51. PubMed ID: 10497636
[TBL] [Abstract][Full Text] [Related]
12. High frequency of non-Hodgkin's lymphoma in patients with HIV-associated Kaposi's sarcoma.
Ridolfo AL; Santambrogio S; Mainini F; Vago L; Gervasoni C; Gori A; Parravicini C; Monforte A; Galli M
AIDS; 1996 Feb; 10(2):181-5. PubMed ID: 8838706
[TBL] [Abstract][Full Text] [Related]
13. ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN'S LYMPHOMA AND KAPOSI'S SARCOMA.
Petroianu A; Alberti LR; Orsi VL; Viana FCT; Moura CB
Arq Bras Cir Dig; 2020; 33(2):e1521. PubMed ID: 33237165
[TBL] [Abstract][Full Text] [Related]
14. Study of 172 Cases of AIDS Associated Cancers.
Phatak UA; Gosavi VS; Chitale PV
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062808
[TBL] [Abstract][Full Text] [Related]
15. Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.
Lazzarino T; Martenet S; Mamin R; Du Pasquier RA; Peters S; Perreau M; Muller O; Hugli O; Cavassini M; Darling KEA
BMJ Open; 2018 Oct; 8(10):e021203. PubMed ID: 30287667
[TBL] [Abstract][Full Text] [Related]
16. Immune deficiency and risk for malignancy among persons with AIDS.
Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705
[TBL] [Abstract][Full Text] [Related]
17. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
18. AIDS cancers: conundrums and controversies.
Mascolini M
J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):10-30. PubMed ID: 11364711
[TBL] [Abstract][Full Text] [Related]
19. HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study.
Sengayi M; Babb C; Egger M; Urban MI
BMC Cancer; 2015 Mar; 15():144. PubMed ID: 25884599
[TBL] [Abstract][Full Text] [Related]
20. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
